Deep Brain Stimulation for Treatment Resistant Depression
NCT: NCT00367003 · COMPLETED
Brief Summary
The purpose of this study is to test the safety, efficacy and mechanism of action of subgenual cingulate (Cg25) deep brain stimulation (DBS) for major depression in patients who have not responded to prior antidepressant treatments. Participation in the study will continue for ten years or until the device receives FDA approval for depression. Forty (40) patients will be enrolled in this study.
Frequently Asked Questions
What is Deep Brain Stimulation for Treatment Resistant Depression?
Deep Brain Stimulation for Treatment Resistant Depression is a clinical trial registered under NCT00367003. Current status: COMPLETED.
What is the status of NCT00367003?
The current status of NCT00367003 (Deep Brain Stimulation for Treatment Resistant Depression) is: COMPLETED.
When did Deep Brain Stimulation for Treatment Resistant Depression start?
Deep Brain Stimulation for Treatment Resistant Depression started on 2006-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.